1 – 3 of 3
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
(
- Contribution to journal › Article
- 2009
-
Mark
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
(
- Contribution to journal › Article
- 2008
-
Mark
The EUROclass trial: defining subgroups in common variable immunodeficiency.
(
- Contribution to journal › Article